objective the purpose of this study was to determine the prevalence and the most common risk factors of motor developmental delay in infants. materials & methods following ethical approval, a study was carried out on the prevalence and risk factors of infants with motor developmental delay. the first stage was conducted through a cross-sectional study to determine the prevalence of motor develo...

in 2006, the American Academy of Pediatrics (AAP) formally recommended the use of developmental surveillance at each well child visit and the use of standardized developmental screening tools at nine, 18, and 30 (or 24) month visits. In 2007 the AAP recommended the incorporation of an autism-specific screening at the 18 and 24-month visits. In 2006 the Rhode Island Department of Health conducte...

According to the literature, 12 to 16 percent of children in the United States have at least one developmental delay, yet as many as one-half of affected children will not be identified by the time they enter kindergarten. If developmental delays are detected too late, opportunities for early intervention may be lost. Empirical literature on clinical recommendations for developmental delay scre...

Little is known about the current practices of primary care physicians regarding developmental surveillance and screening during pediatric preventive care visits. We conducted a mailed survey of a random national sample of pediatricians and family physicians to describe their practices and identify factors that predict use of developmental screening tools, an efficacious way of identifying chil...

Background: Autism is a neurodevelopmental disorder that onset in the first 3 years of life and led to lifelong disability.Despite the early onset of symptoms, diagnosis of thissyndromedoes not happenuntil severalyears later, somany childrenlosethe opportunityfor earlyintervention.There arevarious toolsforscreening anddiagnosis, buttheirdesign, strengths and weaknesses aredifferent. The aim of ...

INTRODUCTION Global developmental delay (GDD) affects 1%-3% of the population of children under 5 years of age, making it one of the most common conditions presenting in paediatric clinics; causes are exogenous, genetic (non-metabolic) or genetic (metabolic). Recent advances in biotechnology and genetic testing mean that the investigations available to perform for children under 5 years are inc...

BACKGROUND AND OBJECTIVES Screening, early identification, and referral improves outcomes for young children at risk for developmental delays. Effective developmental screening processes should include efforts to ensure referral completion and documentation of evaluation results and service eligibility in the child's medical record. Our objectives were to improve provider documentation of actio...